Analysts Set Owens & Minor, Inc. (OMI) Target Price at $19.00

Shares of Owens & Minor, Inc. (NYSE:OMI) have received a consensus recommendation of “Sell” from the eight analysts that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a sell rating and three have issued a hold rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $12.50.

OMI has been the subject of a number of research reports. Zacks Investment Research cut shares of Owens & Minor from a “hold” rating to a “sell” rating in a research note on Wednesday, July 11th. Bank of America cut shares of Owens & Minor from a “buy” rating to a “neutral” rating in a research report on Wednesday, October 31st. Leerink Swann set a $9.00 price target on shares of Owens & Minor and gave the company a “hold” rating in a research report on Wednesday, October 31st. Barclays reissued an “underweight” rating and set a $8.00 price target (down previously from $12.00) on shares of Owens & Minor in a research report on Thursday, November 1st. Finally, Jefferies Financial Group reissued a “hold” rating and set a $8.50 price target on shares of Owens & Minor in a research report on Friday, November 2nd.

In other Owens & Minor news, SVP Charles C. Colpo sold 11,000 shares of the stock in a transaction on Monday, August 27th. The shares were sold at an average price of $16.87, for a total transaction of $185,570.00. Following the completion of the sale, the senior vice president now owns 20,944 shares of the company’s stock, valued at approximately $353,325.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Charles C. Colpo sold 12,000 shares of the company’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $16.31, for a total transaction of $195,720.00. Following the completion of the transaction, the senior vice president now owns 31,944 shares of the company’s stock, valued at $521,006.64. The disclosure for this sale can be found here. Insiders have sold a total of 31,516 shares of company stock valued at $513,288 in the last three months. 2.04% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Itau Unibanco Holding S.A. bought a new position in Owens & Minor in the 2nd quarter worth $170,000. Xact Kapitalforvaltning AB bought a new position in Owens & Minor in the 1st quarter worth $171,000. Summit X LLC bought a new position in Owens & Minor in the 2nd quarter worth $181,000. NumerixS Investment Technologies Inc raised its holdings in Owens & Minor by 74.6% in the 2nd quarter. NumerixS Investment Technologies Inc now owns 11,000 shares of the company’s stock worth $189,000 after purchasing an additional 4,700 shares in the last quarter. Finally, Glen Harbor Capital Management LLC raised its holdings in Owens & Minor by 47.4% in the 2nd quarter. Glen Harbor Capital Management LLC now owns 11,928 shares of the company’s stock worth $199,000 after purchasing an additional 3,836 shares in the last quarter. Institutional investors and hedge funds own 88.95% of the company’s stock.

Shares of Owens & Minor stock traded down $0.18 during trading on Wednesday, reaching $9.10. The company’s stock had a trading volume of 1,679,100 shares, compared to its average volume of 1,123,994. Owens & Minor has a 52-week low of $7.86 and a 52-week high of $22.91. The stock has a market capitalization of $586.41 million, a price-to-earnings ratio of 5.65, a price-to-earnings-growth ratio of 1.81 and a beta of 1.66. The company has a debt-to-equity ratio of 2.08, a quick ratio of 0.91 and a current ratio of 1.77.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $0.32 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.32. Owens & Minor had a negative net margin of 1.57% and a positive return on equity of 9.11%. The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.54 billion. During the same quarter in the prior year, the company earned $0.40 EPS. The firm’s revenue was up 5.6% on a year-over-year basis. On average, equities research analysts forecast that Owens & Minor will post 1.22 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 2nd. Shareholders of record on Monday, December 17th will be given a dividend of $0.075 per share. The ex-dividend date of this dividend is Friday, December 14th. This represents a $0.30 annualized dividend and a yield of 3.30%. Owens & Minor’s payout ratio is currently 64.60%.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It operates through three segments: Domestic, International, and Proprietary Products. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.

See Also: Fundamental Analysis and Individual Investors

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply